Michael J. Tokich Sells 12,000 Shares of Steris Plc (STE) Stock
Steris Plc (NYSE:STE) insider Michael J. Tokich sold 12,000 shares of the stock in a transaction dated Wednesday, October 4th. The stock was sold at an average price of $89.75, for a total transaction of $1,077,000.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
Shares of Steris Plc (STE) traded down 0.56% on Friday, reaching $90.51. 271,653 shares of the company’s stock traded hands. Steris Plc has a 52 week low of $63.80 and a 52 week high of $91.18. The company has a 50 day moving average price of $86.95 and a 200 day moving average price of $79.82. The firm has a market capitalization of $7.71 billion, a price-to-earnings ratio of 64.74 and a beta of 1.29.
Steris Plc (NYSE:STE) last released its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. Steris Plc had a net margin of 4.63% and a return on equity of 11.39%. The company had revenue of $608.00 million for the quarter, compared to the consensus estimate of $597.66 million. During the same period in the previous year, the firm earned $0.79 EPS. Steris Plc’s revenue was down 4.8% on a year-over-year basis. On average, equities research analysts predict that Steris Plc will post $4.06 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Thursday, September 28th. Shareholders of record on Tuesday, August 29th were given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.37%. This is an increase from Steris Plc’s previous quarterly dividend of $0.28. The ex-dividend date was Friday, August 25th. Steris Plc’s payout ratio is 88.57%.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/10/06/michael-j-tokich-sells-12000-shares-of-steris-plc-ste-stock.html.
Hedge funds have recently added to or reduced their stakes in the business. Citigroup Inc. bought a new stake in shares of Steris Plc in the 2nd quarter worth approximately $206,000. Van Cleef Asset Management Inc bought a new stake in shares of Steris Plc in the 2nd quarter worth approximately $208,000. Cigna Investments Inc. New bought a new stake in shares of Steris Plc in the 2nd quarter worth approximately $209,000. BT Investment Management Ltd bought a new stake in shares of Steris Plc in the 2nd quarter worth approximately $210,000. Finally, Aureus Asset Management LLC bought a new stake in shares of Steris Plc in the 1st quarter worth approximately $245,000. Institutional investors own 93.33% of the company’s stock.
Several research firms recently issued reports on STE. Zacks Investment Research cut shares of Steris Plc from a “buy” rating to a “hold” rating in a report on Tuesday, August 22nd. Raymond James Financial, Inc. increased their price target on shares of Steris Plc from $90.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, August 9th. Finally, BidaskClub cut shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. Steris Plc currently has an average rating of “Buy” and a consensus price target of $86.75.
Steris Plc Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with MarketBeat.com's FREE daily email newsletter.